- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/00 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patent holdings for IPC class C07D 265/00
Total number of patents in this class: 54
10-year publication summary
|
1
|
0
|
2
|
0
|
3
|
0
|
2
|
4
|
3
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| RespireRx Pharmaceuticals Inc | 10 |
4 |
| BASF SE | 20945 |
3 |
| Xerox Corporation | 6999 |
2 |
| Janssen Pharmaceutica N.V. | 3377 |
2 |
| Allergan, Inc. | 2340 |
2 |
| University of Miami | 844 |
2 |
| Antengene Discovery Limited | 14 |
2 |
| Samsung Electronics Co., Ltd. | 147003 |
1 |
| Bristol-myers Squibb Company | 4881 |
1 |
| F. Hoffmann-La Roche AG | 7945 |
1 |
| Merck Sharp & Dohme Corp. | 2191 |
1 |
| Boehringer Ingelheim International GmbH | 4641 |
1 |
| Abbott Laboratories | 2400 |
1 |
| Bayer Cropscience AG | 2038 |
1 |
| The Johns Hopkins University | 5679 |
1 |
| Alios BioPharma, Inc. | 65 |
1 |
| Alkermes Pharma Ireland Limited | 270 |
1 |
| AMOREPACIFIC Corporation | 2844 |
1 |
| Aurigene Discovery Technologies Limited | 99 |
1 |
| Baden-Württemberg Stiftung gGmbH | 67 |
1 |
| Other owners | 24 |